Delisting risk
Ernexa Therapeutics (ERNA)
Develops off-the-shelf engineered iMSC therapies for cancer and autoimmune disease.
$4.54
Pre-market+0.04 (+1.00%)
At close$4.50(+3.33%)
Something off on this page? Send us feedback.
Next report
Nov 6, 2026
estimated · in 64 days
EPS estimate
−$3.84
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$48.00−$2.25−$0.61−$0.15−$0.25−$6.95−$3.40Pending
Estimate−$37.50−$48.00−$39.00−$33.00—−$1.95−$3.30−$3.84
Surprise−28.0%+95.3%+98.4%+99.5%—−256.4%−3.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.0K——————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$3.84 | — | — |
| Aug 2026 | −$3.30 | −$3.40 | −3.0% |
| May 2026 | −$1.95 | −$6.95 | −256.4% |
| Mar 2026 | — | −$0.25 | — |
| Nov 2025 | −$33.00 | −$0.15 | +99.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | — | — | — |
| Oct 2019 | −$1.20 | — | — |
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 | — | — | — |
| Mar 2015 | — | — | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | −$3.84 | — | — | — | — | — | — |
| Aug 6, 2026 | −$3.30 | −$3.40 | −3.0% | — | — | — | +6.3% |
| May 11, 2026 | −$1.95 | −$6.95 | −256.4% | — | — | — | +66.6% |
| Mar 13, 2026 | — | −$0.25 | — | — | — | — | −6.8% |
| Nov 7, 2025 | −$33.00 | −$0.15 | +99.5% | — | — | — | −4.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 13, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 20, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 11, 2022 | |||||||
| Jul 1, 2022 | |||||||
| Apr 15, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 11, 2020 | |||||||
| Aug 7, 2020 | |||||||
| May 19, 2020 | |||||||
| Mar 19, 2020 | — | — | — | $6.2M | — | — | — |
| Oct 10, 2019 | −$1.20 | — | — | $6.1M | — | — | — |
| Mar 20, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 3, 2017 | |||||||
| Mar 6, 2017 | |||||||
| Nov 8, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 6, 2016 | |||||||
| Mar 11, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 6, 2015 | |||||||
| May 7, 2015 | — | — | — | — | — | — | — |
| Mar 26, 2015 | — | — | — | — | — | — | — |